Effects of 12 Months' Treatment with Testosterone Undecanoate on Markers for Erythropoietic Activity and Safety Aspects in Transgender and Cisgender Hypogonadal Men.

Lethin, Kajsa; Aardal, Elisabeth; Lood, Yvonne; Ekman, Bertil; Wahlberg, Jeanette

Lethin, Kajsa; Aardal, Elisabeth; Lood, Yvonne; Ekman, Bertil; Wahlberg, Jeanette.

Afiliação

Lethin K; Department of Endocrinology in Linköping, Linköping University, Linköping, Sweden.
Aardal E; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Lood Y; Department of Clinical Chemistry, Linköping University, Linköping, Sweden.
Ekman B; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Wahlberg J; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

J Appl Lab Med ; 9(2): 223-236, 2024 Mar 01.

Article em En | MEDLINE | ID: mdl-38085088

Assuntos

Testosterona; Pessoas Transgênero; Feminino; Humanos; Masculino; HDL-Colesterol; Hemoglobinas; Estudos Prospectivos; Testosterona/análogos & derivados

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testosterona / Pessoas Transgênero Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google